These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17563465)

  • 21. Does reduction in gastric acid secretion in bariatric surgery increase diet-induced thermogenesis?
    Melissas J; Kampitakis E; Schoretsanitis G; Mouzas J; Kouroumalis E; Tsiftsis DD
    Obes Surg; 2002 Jun; 12(3):399-403. PubMed ID: 12082896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.
    Ballantyne GH
    Obes Surg; 2006 Jun; 16(6):795-803. PubMed ID: 16756746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
    Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery.
    Park AM; Storm DW; Fulmer BR; Still CD; Wood GC; Hartle JE
    J Urol; 2009 Nov; 182(5):2334-9. PubMed ID: 19762043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight loss outcome of revisional bariatric operations varies according to the primary procedure.
    Brolin RE; Cody RP
    Ann Surg; 2008 Aug; 248(2):227-32. PubMed ID: 18650632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of correlation between variation in small-volume gastric pouch size and weight loss after laparoscopic Roux-en-Y gastric bypass.
    O'Connor EA; Carlin AM
    Surg Obes Relat Dis; 2008; 4(3):399-403. PubMed ID: 18294920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergency room visits after laparoscopic Roux-en-Y gastric bypass for morbid obesity.
    Cho M; Kaidar-Person O; Szomstein S; Rosenthal RJ
    Surg Obes Relat Dis; 2008; 4(2):104-9. PubMed ID: 17974500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between varying Roux limb lengths and weight loss in gastric bypass.
    Lee S; Sahagian KG; Schriver JP
    Curr Surg; 2006; 63(4):259-63. PubMed ID: 16843777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients.
    Pinheiro JS; Schiavon CA; Pereira PB; Correa JL; Noujaim P; Cohen R
    Surg Obes Relat Dis; 2008; 4(4):521-5; discussion 526-7. PubMed ID: 18539540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine and metabolic response to gastric bypass.
    Saliba J; Wattacheril J; Abumrad NN
    Curr Opin Clin Nutr Metab Care; 2009 Sep; 12(5):515-21. PubMed ID: 19535977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-year outcome with gastric bypass: Roux limb length makes a difference.
    Gleysteen JJ
    Surg Obes Relat Dis; 2009; 5(2):242-7; discussion 247-9. PubMed ID: 18996751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Number of weight loss attempts and maximum weight loss before Roux-en-Y laparoscopic gastric bypass surgery are not predictive of postoperative weight loss.
    Jantz EJ; Larson CJ; Mathiason MA; Kallies KJ; Kothari SN
    Surg Obes Relat Dis; 2009; 5(2):208-11. PubMed ID: 18996769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antireflux operation for gastroesophageal reflux after Roux-en-y gastric bypass for obesity.
    Chen RH; Lautz D; Gilbert RJ; Bueno R
    Ann Thorac Surg; 2005 Nov; 80(5):1938-40. PubMed ID: 16242496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
    Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study.
    Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
    J Surg Res; 2007 Oct; 142(2):295-300. PubMed ID: 17640666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating preoperative weight loss, binge eating disorder, and sexual abuse history on Roux-en-Y gastric bypass outcome.
    Fujioka K; Yan E; Wang HJ; Li Z
    Surg Obes Relat Dis; 2008; 4(2):137-43. PubMed ID: 18359454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary outcomes of laparoscopic adjustable gastric banding and Roux-en-Y gastric bypass in surgical obesity treatment].
    Dadan J; Iwacewicz P; Razak H; Łukaszewicz J; Safiejko K; Wojskowicz P
    Pol Merkur Lekarski; 2007 Nov; 23(137):344-7. PubMed ID: 18361316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of preoperative weight loss in high-risk patients undergoing gastric bypass surgery.
    Still CD; Benotti P; Wood GC; Gerhard GS; Petrick A; Reed M; Strodel W
    Arch Surg; 2007 Oct; 142(10):994-8; discussion 999. PubMed ID: 17938314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ileal transposition provides insight into the effectiveness of gastric bypass surgery.
    Strader AD
    Physiol Behav; 2006 Jun; 88(3):277-82. PubMed ID: 16782138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased gastric cytokine production after Roux-en-Y gastric bypass for morbid obesity.
    Faintuch J; Ishida RK; Jacabi M; Ribeiro AS; Kuga R; Sakai P; Barbeiro HV; Barbeiro DF; Soriano FG; Cecconello I
    Arch Surg; 2007 Oct; 142(10):962-8. PubMed ID: 17938310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.